Neonc Technologies
Neonc Technologies is a United States-based biotechnology company running 3 late-stage cancer trials of NEO212 Oral and NEO100 in glioma & glioblastoma, cervical cancer and colorectal cancer.
Overview
Neonc Technologies, based in Calabasas, the United States, is a biotechnology company listed as NASDAQ: NTHI. NeOnc develops drug delivery therapeutics for central nervous system diseases, using a perillyl-alcohol-based platform intended to transport therapeutics across the blood-brain barrier. On ClinicalTrials.gov it is the lead sponsor of 3 recruiting or active phase 2 and phase 3 interventional cancer trials, testing NEO212 Oral and NEO100 in glioma & glioblastoma, cervical cancer, colorectal cancer, oesophageal cancer and gastric & gastro-oesophageal junction cancer. The largest, NCT06047379 (Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis), plans to enrol 134 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry, checked on 2026-09-11; company facts are from the official website.
Similar pages
not linked directly; found by shared links- CompanyVyriad
Shares Head and neck squamous cell carcinoma, Melanoma, Colorectal cancer and the tag ctgov-sponsor.
- CompanyAveta Biomics
Shares Glioma & glioblastoma, Head and neck squamous cell carcinoma and the tag ctgov-sponsor.
- CompanyAP Biosciences
Shares Oesophageal cancer, Head and neck squamous cell carcinoma and the tag ctgov-sponsor.
- CompanyHangzhou Hanx Biopharmaceuticals
Shares Glioma & glioblastoma, Melanoma and the tag ctgov-sponsor.
- CompanyMultitude Therapeutics
Shares Melanoma, Colorectal cancer and the tag ctgov-sponsor.
- CompanyTiumBio
Shares Head and neck squamous cell carcinoma, Colorectal cancer and the tag ctgov-sponsor.
- CompanyMabwell (Shanghai) Bioscience
Shares Cervical cancer, Colorectal cancer and the tag ctgov-sponsor.
- CompanyShanghai Kechow Pharma
Shares Melanoma, Colorectal cancer and the tag ctgov-sponsor.